The ACS Green Chemistry Institute Pharmaceutical Roundtable was founded in 2005 with the goal of creating a noncompetitive environment for members to share information on how to improve the environmental impact of their business. Over time it became apparent that there were many areas of the pharmaceutical industry worth examining. As a result, several sub teams were created in order to enable a more focused effort on green chemistry in those areas. One such area identified was Medicinal Chemistry, given that the majority of the active roundtable members have their background in process chemistry. While it is still chemistry at its core, Medicinal Chemistry varies significantly from process chemistry in many ways due to the difference in deliverables and scale. Therefore a team was formed in 2011 to look more closely at opportunities to have impact on Medicinal Chemistry in the pharmaceutical industry. In the years since the team was formed representation has been steady with 9 companies involved. A summary of the activities and impacts from last 4+ years including publications, presentations and grant collaborations in areas of high interest to medicinal chemistry, will be highlighted here.

Development and impact of the medicinal chemistry sub-team of the ACS GCI pharmaceutical roundtable

251st National Meeting (2016)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.